Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Usability of an AI for M923 in Subjects With Moderate to Severe RA

ClinicalTrials.gov ID: NCT02722044

Public ClinicalTrials.gov record NCT02722044. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 7:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Single-arm Multicenter Study to Evaluate Usability of a Subcutaneous (SC) Autoinjector (AI) for a Proposed Adalimumab Biosimilar (M923) in Subjects With Moderate to Severe Rheumatoid Arthritis (RA)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the usability of an auto-injector (AI) for the delivery of M923 in patients with rheumatoid arthritis (RA)

Study identification

NCT ID
NCT02722044
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Momenta Pharmaceuticals, Inc.
Industry
Enrollment
33 participants

Conditions and interventions

Interventions

Biological · Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2016 (Type not available)
Primary completion
Feb 21, 2017 (Actual)
Completion
Feb 21, 2017 (Actual)
Last update posted
May 16, 2018

2016 – 2017

United States locations

U.S. sites
7
U.S. states
5
U.S. cities
6
Facility City State ZIP Site status
Henry Ford Health System Detroit Michigan 48202 —
Medication Management, LLC Greensboro North Carolina 27408 —
Lynn Health Science Institute Oklahoma City Oklahoma 73112 —
Altoona Center for Clinical Research, PC Duncansville Pennsylvania 16635 —
Austin Regional Clinic, PA Austin Texas 78731 —
Accurate Clinical Management Houston Texas 77004 —
Accurate Clinical Research, Inc. Houston Texas 77034 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02722044, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 16, 2018 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02722044 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →